functional_bowel_symptoms_rome_iii
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
functional_bowel_symptoms_rome_iii [2019/11/14 14:01] lifelines |
functional_bowel_symptoms_rome_iii [2019/11/14 14:06] lifelines |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Functional Bowel Symptoms (Rome III) ====== | ====== Functional Bowel Symptoms (Rome III) ====== | ||
| - | The Rome III IBS Diagnostic Questionnaire is a survey to assess whether individuals meet the diagnostic criteria for [[https://en.wikipedia.org/wiki/Irritable_bowel_syndrome|Irritable Bowel Syndrome (IBS)]] ([[sections|section]]: [[Diseases & symptoms]]).\\ | + | The Rome III IBS Diagnostic Questionnaire is a survey to assess whether individuals meet the diagnostic criteria for [[https://en.wikipedia.org/wiki/Irritable_bowel_syndrome|Irritable Bowel Syndrome (IBS)]]((Whitehead WE et al. (2006) Development and validation of the Rome III diagnostic questionnaire. In Rome III: The Functional Gastrointestinal Disorders, 3rd edn Degnon Associates: McLean, VA, 835–853))([[sections|section]]: [[Diseases & symptoms]]).\\ |
| The Rome III diagnostic criteria are set forth by the [[https://theromefoundation.org/|Rome Foundation]].\\ | The Rome III diagnostic criteria are set forth by the [[https://theromefoundation.org/|Rome Foundation]].\\ | ||
| The Rome III Survey was implemented in [[start|Lifelines]] general assessment [[2A]] and was used in additional assessments on intestinal health and microbiome ([[DEEP]] and [[DAG3]]). | The Rome III Survey was implemented in [[start|Lifelines]] general assessment [[2A]] and was used in additional assessments on intestinal health and microbiome ([[DEEP]] and [[DAG3]]). | ||
| ===== Background ===== | ===== Background ===== | ||
| - | Lifelines repeatedly assessed the presence of IBS by [[digestive diseases|self-report]]. However, recent studies indicate that this method misses ~69% of IBS diagnoses((Whitehead WE et al. (2006) Development and validation of the Rome III diagnostic questionnaire. In Rome III: The Functional Gastrointestinal Disorders, 3rd edn Degnon Associates: McLean, VA, 835–853)).\\ | + | Lifelines repeatedly assessed the presence of IBS by [[digestive diseases|self-report]]. However, recent studies indicate that this method misses ~69% of IBS diagnoses((Warren JW, Clauw DJ (2012). Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis. Psychosomatic Medicine 74(9):891-895)). The Rome III IBS DQ improves the identification of participants that meet the diagnostic criteria for IBS by assessing the presence of individual symptoms rather than the disease itself. The instrument is able to distinguish between IBS and functional [[https://en.wikipedia.org/wiki/Functional_constipation|constipation]], functional [[https://en.wikipedia.org/wiki/Bloating|bloating]] and functional [[https://en.wikipedia.org/wiki/Diarrhea|diarrhea]].\\ |
| - | The Rome III IBS DQ assesses whether participants meet the diagnostic criteria for IBS, and is able to distinguish between IBS and functional [[https://en.wikipedia.org/wiki/Functional_constipation|constipation]], functional [[https://en.wikipedia.org/wiki/Bloating|bloating]] and functional [[https://en.wikipedia.org/wiki/Diarrhea|diarrhea]].\\ | + | |
| - | The Rome III survey is currently superseded by the Rome IV survey. | + | |
| ===== Scoring ===== | ===== Scoring ===== | ||
| Line 18: | Line 16: | ||
| ===== Validity ===== | ===== Validity ===== | ||
| - | Factor analysis confirms consistent clusters of symptoms corresponding to IBS; symptom-based criteria agree reasonably well (sensitivity, 0.4-0.9) with clinical diagnoses made by experienced clinicians; and patients with a clinical diagnosis of IBS who fulfill Rome II criteria have greater symptom severity and poorer quality of life than patients with a clinical diagnosis of IBS who do not fulfill Rome criteria. There are no consistent differences in sensitivity or specificity between Manning, Rome I, and Rome II. Both study types support the validity of symptom-based IBS criteria ((Whitehead WE and Drossman DA (2010). Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol. 105(4):814-20)). | + | * Factor analysis confirms consistent clusters of symptoms corresponding to IBS; symptom-based criteria agree reasonably well (sensitivity, 0.4-0.9) with clinical diagnoses made by experienced clinicians; and patients with a clinical diagnosis of IBS who fulfill Rome II criteria have greater symptom severity and poorer quality of life than patients with a clinical diagnosis of IBS who do not fulfill Rome criteria. There are no consistent differences in sensitivity or specificity between Manning, Rome I, and Rome II. Both study types support the validity of symptom-based IBS criteria((Whitehead WE and Drossman DA (2010). Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol. 105(4):814-20)). |
| - | Tests of Rome III are needed. However, one study comparing Rome II and Rome III criteria for IBS and its subtypes (IBS-C, D, M) within the same patient cohort (Female patients (n=148) with Rome II defined IBS showed excellent agreement (86.5%, κ=0.79), and the behavior of these patients were similar in terms of subtype prevalence and stability over a 1-year period ((Dorn SD et al. (2009) Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol 43:214–220)). | + | * Tests of Rome III are needed. However, one study comparing Rome II and Rome III criteria for IBS and its subtypes (IBS-C, D, M) within the same patient cohort (Female patients (n=148) with Rome II defined IBS showed excellent agreement (86.5%, κ=0.79), and the behavior of these patients were similar in terms of subtype prevalence and stability over a 1-year period((Dorn SD et al. (2009) Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol 43:214–220)). |
| ===== Variables ===== | ===== Variables ===== | ||
functional_bowel_symptoms_rome_iii.txt · Last modified: 2021/10/27 12:57 by laura
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
